nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
|
Shih, Ted |
|
2006 |
28 |
11 |
p. 1779-1802 24 p. |
artikel |
2 |
Cardiovascular events associated with the use of four nonselective NSAIDs (Etodolac, Nabumetone, Ibuprofen, or Naproxen) Versus a Cyclooxygenase-2 Inhibitor (Celecoxib): A population-based analysis in taiwanese adults
|
Huang, Weng-Foung |
|
2006 |
28 |
11 |
p. 1827-1836 10 p. |
artikel |
3 |
Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-Receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: A decision-analytic model
|
Borg, Sixten |
|
2006 |
28 |
11 |
p. 1947-1959 13 p. |
artikel |
4 |
Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with Schizophrenia in Quebec and Saskatchewan: A retrospective database study
|
Ward, Alexandra |
|
2006 |
28 |
11 |
p. 1912-1921 10 p. |
artikel |
5 |
Correction
|
|
|
2006 |
28 |
11 |
p. 1970- 1 p. |
artikel |
6 |
Correction
|
|
|
2006 |
28 |
11 |
p. 1968-1969 2 p. |
artikel |
7 |
Correction
|
|
|
2006 |
28 |
11 |
p. 1967- 1 p. |
artikel |
8 |
Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: A Canadian perspective
|
Tarride, Jean-Eric |
|
2006 |
28 |
11 |
p. 1922-1934 13 p. |
artikel |
9 |
Effects of ibuprofen on sleep quality as measured using polysomnography and subjective measures in healthy adults
|
Gengo, Francis |
|
2006 |
28 |
11 |
p. 1820-1826 7 p. |
artikel |
10 |
Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: A retrospective study in patients undergoing primary percutaneous coronary intervention
|
Ishii, Hideki |
|
2006 |
28 |
11 |
p. 1812-1819 8 p. |
artikel |
11 |
Eradication of Helicobacter pylori with triple therapy:An epidemiologic analysis of trends in Turkey over 10 years
|
Kadayifci, Abdurrahman |
|
2006 |
28 |
11 |
p. 1960-1966 7 p. |
artikel |
12 |
Expanding options with a wider range of rosuvastatin doses
|
Olsson, Anders G. |
|
2006 |
28 |
11 |
p. 1747-1763 17 p. |
artikel |
13 |
Gatifloxacin-induced hyperglycemia: A case report and summary of the current literature
|
Yip, Clifford |
|
2006 |
28 |
11 |
p. 1857-1866 10 p. |
artikel |
14 |
Introduction to remission in ADHD: Raising the bar
|
Steele, Margaret |
|
2006 |
28 |
11 |
p. 1879-1881 3 p. |
artikel |
15 |
Measurable outcomes in psychiatric disorders: Remission as a marker of wellness
|
McIntyre, Roger S. |
|
2006 |
28 |
11 |
p. 1882-1891 10 p. |
artikel |
16 |
Patients' and physicians' perceptions of the travoprost dosing aid: An open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension
|
Flowers, Brian |
|
2006 |
28 |
11 |
p. 1803-1811 9 p. |
artikel |
17 |
Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: A randomized, open-label, two-period, comparative, crossover study
|
Park, Ji-Young |
|
2006 |
28 |
11 |
p. 1837-1847 11 p. |
artikel |
18 |
Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: A randomized, open-label study
|
Zhao, June |
|
2006 |
28 |
11 |
p. 1868-1876 9 p. |
artikel |
19 |
Remission versus response as the goal of therapy in ADHD: A new standard for the field?
|
Steele, Margaret |
|
2006 |
28 |
11 |
p. 1892-1908 17 p. |
artikel |
20 |
Role of abatacept in the management of rheumatoid arthritis
|
Nogid, Anna |
|
2006 |
28 |
11 |
p. 1764-1778 15 p. |
artikel |
21 |
Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys
|
Trattler, William |
|
2006 |
28 |
11 |
p. 1848-1856 9 p. |
artikel |
22 |
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: The VESIcare open-label trial (VOLT)
|
Garely, Alan D. |
|
2006 |
28 |
11 |
p. 1935-1946 12 p. |
artikel |
23 |
The uninsured and underinsured in the United States: The saga continues
|
Coons, Stephen Joel |
|
2006 |
28 |
11 |
p. 1910-1911 2 p. |
artikel |